BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27613834)

  • 1. Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous nature.
    Jung J; Lee CH; Seol HS; Choi YS; Kim E; Lee EJ; Rhee JK; Singh SR; Jun ES; Han B; Hong SM; Kim SC; Chang S
    Oncotarget; 2016 Sep; 7(38):62533-62546. PubMed ID: 27613834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines.
    Woo XY; Srivastava A; Graber JH; Yadav V; Sarsani VK; Simons A; Beane G; Grubb S; Ananda G; Liu R; Stafford G; Chuang JH; Airhart SD; Karuturi RKM; George J; Bult CJ
    BMC Med Genomics; 2019 Jul; 12(1):92. PubMed ID: 31262303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.
    Woo XY; Giordano J; Srivastava A; Zhao ZM; Lloyd MW; de Bruijn R; Suh YS; Patidar R; Chen L; Scherer S; Bailey MH; Yang CH; Cortes-Sanchez E; Xi Y; Wang J; Wickramasinghe J; Kossenkov AV; Rebecca VW; Sun H; Mashl RJ; Davies SR; Jeon R; Frech C; Randjelovic J; Rosains J; Galimi F; Bertotti A; Lafferty A; O'Farrell AC; Modave E; Lambrechts D; Ter Brugge P; Serra V; Marangoni E; El Botty R; Kim H; Kim JI; Yang HK; Lee C; Dean DA; Davis-Dusenbery B; Evrard YA; Doroshow JH; Welm AL; Welm BE; Lewis MT; Fang B; Roth JA; Meric-Bernstam F; Herlyn M; Davies MA; Ding L; Li S; Govindan R; Isella C; Moscow JA; Trusolino L; Byrne AT; Jonkers J; Bult CJ; Medico E; Chuang JH; ;
    Nat Genet; 2021 Jan; 53(1):86-99. PubMed ID: 33414553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts).
    Hernández Guerrero T; Baños N; Del Puerto Nevado L; Mahillo-Fernandez I; Doger De-Speville B; Calvo E; Wick M; García-Foncillas J; Moreno V
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001663
    [No Abstract]   [Full Text] [Related]  

  • 5. Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice.
    Zeng M; Ruan Z; Tang J; Liu M; Hu C; Fan P; Dai X
    Cancer Cell Int; 2023 Jun; 23(1):120. PubMed ID: 37344821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation Potential and Challenges of In Vitro and Murine Models in Cancer Clinic.
    Long Y; Xie B; Shen HC; Wen D
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current methods for studying metastatic potential of tumor cells.
    Bouchalova P; Bouchal P
    Cancer Cell Int; 2022 Dec; 22(1):394. PubMed ID: 36494720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zebrafish Patient-Derived Xenograft Model to Predict Treatment Outcomes of Colorectal Cancer Patients.
    Di Franco G; Usai A; Piccardi M; Cateni P; Palmeri M; Pollina LE; Gaeta R; Marmorino F; Cremolini C; Dente L; Massolo A; Raffa V; Morelli L
    Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis.
    Choi YS; Kim MJ; Choi EA; Kim S; Lee EJ; Park MJ; Kim MJ; Kim YW; Ahn HS; Jung JY; Jang G; Kim Y; Kim H; Kim K; Kim JY; Hong SM; Kim SC; Chang S
    Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2119048119. PubMed ID: 35858411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery.
    Bae J; Choi YS; Cho G; Jang SJ
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicellular Modelling of Difficult-to-Treat Gastrointestinal Cancers: Current Possibilities and Challenges.
    Hakuno SK; Michiels E; Kuhlemaijer EB; Rooman I; Hawinkels LJAC; Slingerland M
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms.
    Sharma M; Arora I; Chen M; Wu H; Crowley MR; Tollefsbol TO; Li Y
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model.
    Jung JY; Ryu HJ; Lee SH; Kim DY; Kim MJ; Lee EJ; Ryu YM; Kim SY; Kim KP; Choi EY; Ahn HJ; Chang S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids.
    Low RRJ; Lim WW; Nguyen PM; Lee B; Christie M; Burgess AW; Gibbs P; Grimmond SM; Hollande F; Putoczki TL
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review.
    Tanaka T; Nishie R; Ueda S; Miyamoto S; Hashida S; Konishi H; Terada S; Kogata Y; Sasaki H; Tsunetoh S; Taniguchi K; Komura K; Ohmichi M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients.
    Usai A; Di Franco G; Piccardi M; Cateni P; Pollina LE; Vivaldi C; Vasile E; Funel N; Palmeri M; Dente L; Falcone A; Giunchi D; Massolo A; Raffa V; Morelli L
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted eicosanoids profiling reveals a prostaglandin reprogramming in breast Cancer by microRNA-155.
    Kim S; Lee ES; Lee EJ; Jung JY; Lee SB; Lee HJ; Kim J; Kim HJ; Lee JW; Son BH; Gong G; Ahn SH; Chang S
    J Exp Clin Cancer Res; 2021 Jan; 40(1):43. PubMed ID: 33494773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Essential Factors of Establishing Patient-derived Tumor Model.
    Chen C; Lin W; Huang Y; Chen X; Wang H; Teng L
    J Cancer; 2021; 12(1):28-37. PubMed ID: 33391400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer.
    Xu W; Zhao ZY; An QM; Dong B; Lv A; Li CP; Guan XY; Tian XY; Wu JH; Hao CY
    Int J Med Sci; 2020; 17(18):3073-3081. PubMed ID: 33173428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of B-NDG
    Guan L; Zou Q; Liu Q; Chen S
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1200-1206. PubMed ID: 32895183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.